MFG
ESLAW icon

Magnus Financial Group’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Magnus Financial Group’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,695
Closed -$3.77K – 290
2023
Q3 		$3.77K Buy
+15,695
New +$2.6K ﹤0.01% 263

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Magnus Financial Group's ESLAW Position: Q4 2023 in Review

Magnus Financial Group sold out of Estrella Immunopharma Warrant (ESLAW) in Q4 2023, closing a stake of 15,695 shares — an estimated $3.77K sold.

Magnus Financial Group first reported a position in ESLAW in Q3 2023 and held it in 1 quarter. The position peaked at $3.77K in Q3 2023. 13 funds tracked by Wall St. Rank hold ESLAW as of Q4 2023.

  • Magnus Financial Group reported no remaining Estrella Immunopharma Warrant position as of Q4 2023 after selling out during the quarter.
  • Magnus Financial Group sold 15,695 Estrella Immunopharma Warrant shares in Q4 2023, an estimated $3.77K.
  • Magnus Financial Group first reported a position in Estrella Immunopharma Warrant in Q3 2023 and held it in 1 quarter.
  • Magnus Financial Group's Estrella Immunopharma Warrant position peaked at $3.77K in Q3 2023.
  • 13 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q4 2023.

Based on Magnus Financial Group's 13F filing for Q4 2023, filed 5 Feb 2024.